Group One Trading
TCRR

Group One Trading’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Group One Trading’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,600
Closed -$15K – 8375
2022
Q3 		$15K Buy
8,600
+2,000
+30% +$5.8K ﹤0.01% 6273
2022
Q2 		$19K Buy
+6,600
New +$16.3K ﹤0.01% 6346
2022
Q1 		– Sell
-300
Closed -$1K – 9007
2021
Q4 		$1K Sell
300
-26,500
-99% -$166K ﹤0.01% 8076
2021
Q3 		$228K Hold
26,800
– – ﹤0.01% 5035
2021
Q2 		$440K Buy
+26,800
New +$541K ﹤0.01% 4354
2020
Q4 		– Sell
-500
Closed -$10K – 7181
2020
Q3 		$10K Buy
+500
New +$8.78K ﹤0.01% 5441

Group One Trading's TCRR Position: Q2 2023 in Review

Group One Trading sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q2 2023, closing a stake of 800 shares — an estimated $1.2K sold.

Group One Trading first reported a position in TCRR in Q1 2022 and held it in 3 quarters. The position peaked at $2K in Q2 2022. 0 funds tracked by Wall St. Rank hold TCRR as of Q2 2023.

  • Group One Trading reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Group One Trading sold 800 TCR2 Therapeutics Inc. Common Stock shares in Q2 2023, an estimated $1.2K.
  • Group One Trading first reported a position in TCR2 Therapeutics Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Group One Trading's TCR2 Therapeutics Inc. Common Stock position peaked at $2K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.